The latest biotechnology news | Bio News
josh-appel-0nkFvdcM-X4-unsplash

This November, we’re giving thanks for 53 million family caregivers

November is National Family Caregivers Month, and this Thanksgiving, we want to honor ...
Read More
martin-krchnacek-vQj_hpDLcII-unsplash

Deforestation brings diseases – but no one bats an eye

New research on Australian fruit bats explains why it has been well-known that ...
Read More
pills-g5d2f80197_1280

New U.N. AMR platform will address global impact of antimicrobial resistance

The Food and Agriculture Organization of the United Nations (FAO), the UN Environment ...
Read More
innovation-gbf4d798c7_1280

Illinois announces $5 million grant-match program to boost innovation

Illinois Governor J.B. Pritzker has announced $5 million in state-funded grants for businesses ...
Read More
pfizer-comirnaty-TRIPS

Pfizer says bivalent booster outperforms original vaccine against variants

BIO members Pfizer and BioNTech’s Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine “elicits a greater ...
Read More
noaa-NBwP2jjnATE-unsplash

COP27 concludes with historic climate deal and mission for biotech

COP27, the UN Climate Change Conference, concluded Friday, with important progress and a ...
Read More

EDITORS' CHOICE

Crowley PBMs

BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices

Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Read More

LATEST NEWS

Latest News

SBIR reauthorization, a top BIO priority, is passed by Congress

Reauthorization of federal seed funding, a top priority for BIO’s work with Congress, passed the House with hefty bipartisan support on March 17 and is ...
BIO's View

BIO on the American Road in Puerto Rico: ‘Medicine Cabinet’ ready to reshore

Known as “America’s Medicine Cabinet,” Puerto Rico is working to maintain its leadership in U.S. biotech production by becoming a hub for reshoring pharmaceutical manufacturing. ...
BIO Events

BIG Summit themes: Resilient investment, MFN threat, patients in the center

The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders in the biotech industry to catch up on domestic and international policy ...
BIO Events

BIG Summit panel breaks down risks and opportunities coming out of DC

Washington’s healthcare policy landscape is constantly evolving, and 2026 is shaping up to be another consequential year for the biotech industry. Some developments are positive, ...
BIO's View

The hidden layer of PBMs: What a recent investigation reveals

With health care affordability a top concern for many Americans, pharmacy benefit managers (PBMs) continue to stand at the center of the debate. Working with ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

State Policy

International

Bio's View

Scroll to Top